We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Herbal formula comparable with anti-hypertension drugs
A multi-centre clinical trial conducted in China has found that a Chinese herbal formula may have therapeutic value in patients with both hypertension and metabolic syndrome, comparing favourably with the anti-hypertension drug irbesartan.
Already subscribed?
Not yet subscribed?
Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:
- Access to the Research Archive
- Access to the Article Archive
- Three printed issues per year